Morgan Stanley’s Monopar Therapeutics MNPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $284K | Buy |
|
|||||
|
2025
Q1 | $51.8K | Sell |
|
|||||
|
2024
Q4 | $83.6K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $545 | Sell |
|
|||||
|
2023
Q4 | $544 | Buy |
|
|||||
|
2023
Q3 | $496 | Sell |
|
|||||
|
2023
Q2 | $3.42K | Hold |
|
|||||
|
2023
Q1 | $5.56K | Hold |
|
|||||
|
2022
Q4 | $9.48K | Hold |
|
|||||
|
2022
Q3 | $6K | Hold |
|
|||||
|
2022
Q2 | $9K | Sell |
|
|||||
|
2022
Q1 | $10K | Buy |
|
|||||
|
2021
Q4 | $13K | Hold |
|
|||||
|
2021
Q3 | $19K | Hold |
|
|||||
|
2021
Q2 | $24K | Buy |
|
|||||
|
2021
Q1 | $20K | Hold |
|
|||||
|
2020
Q4 | $20K | Hold |
|
|||||
|
2020
Q3 | $17K | Hold |
|
|||||
|
2020
Q2 | $24K | Hold |
|
|||||
|
2020
Q1 | $23K | Sell |
|
|||||
|
2019
Q4 | $177K | Buy |
|